99 related articles for article (PubMed ID: 35419093)
41. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
Orsini A; Corsi M; Santangelo A; Riva A; Peroni D; Foiadelli T; Savasta S; Striano P
Neurol Sci; 2020 Sep; 41(9):2353-2366. PubMed ID: 32767055
[TBL] [Abstract][Full Text] [Related]
42. Cross-sectional Imaging Manifestations of Extrapulmonary Involvement in COVID-19 Disease.
Laya BF; Cledera THC; Lim TRU; Baluyut JMP; Medina JMP; Pasia NV
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):253-262. PubMed ID: 33186179
[TBL] [Abstract][Full Text] [Related]
43. Neurological complications of COVID-19: from bridesmaid to bride.
Nath A; Smith B
Arq Neuropsiquiatr; 2020 Sep; 78(8):459-460. PubMed ID: 32901698
[No Abstract] [Full Text] [Related]
44. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
Cunningham JL; Virhammar J; Rönnberg B; Dopico XC; Kolstad L; Albinsson B; Kumlien E; Nääs A; Klang A; Westman G; Zetterberg H; Frithiof R; Lundkvist Å; Karlsson Hedestam GB; Rostami E
J Infect Dis; 2022 Mar; 225(6):965-970. PubMed ID: 33744954
[TBL] [Abstract][Full Text] [Related]
45. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
[TBL] [Abstract][Full Text] [Related]
46. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
47. Neurologic Manifestations and Complications of COVID-19.
Hensley MK; Markantone D; Prescott HC
Annu Rev Med; 2022 Jan; 73():113-127. PubMed ID: 34416121
[TBL] [Abstract][Full Text] [Related]
48. Neurological disease in pregnant females with COVID-19 may not only be attributable to SARS-CoV-2.
Finsterer J
Acta Neurol Scand; 2022 Aug; 146(2):199-200. PubMed ID: 35561124
[No Abstract] [Full Text] [Related]
49. Functional neurological disorder after COVID-19 vaccination.
Ercoli T; Lutzoni L; Orofino G; Muroni A; Defazio G
Neurol Sci; 2021 Oct; 42(10):3989-3990. PubMed ID: 34324120
[No Abstract] [Full Text] [Related]
50. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
[TBL] [Abstract][Full Text] [Related]
51. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
Baig AM; Sanders EC
ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
[TBL] [Abstract][Full Text] [Related]
52. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
53. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
[TBL] [Abstract][Full Text] [Related]
54. Reply to: Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.
Mitchell N
J Neurol Sci; 2021 Sep; 428():117578. PubMed ID: 34311976
[No Abstract] [Full Text] [Related]
55. Neurological Consequences of COVID influencing the Outcome: A Two-way Process.
Krishnan M
J Assoc Physicians India; 2022 Sep; 70(9):11-12. PubMed ID: 36082879
[No Abstract] [Full Text] [Related]
56. Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.
Butler M; Coebergh J; Safavi F; Carson A; Hallett M; Michael B; Pollak TA; Solomon T; Stone J; Nicholson TR;
J Neuropsychiatry Clin Neurosci; 2021; 33(4):345-348. PubMed ID: 34261345
[No Abstract] [Full Text] [Related]
57. Acute and late neurological complications of COVID19: the quest for evidence.
Xiong W; Kwan P; Zhou D; Del Felice A; Duncan JS; Sander JW
Brain; 2020 Dec; 143(12):e99. PubMed ID: 32995833
[No Abstract] [Full Text] [Related]
58. Acute COVID-19 Presenting as Neurological Disease in a Pediatric Patient.
Crowder F; Ebbert M; Neeley B; Mains N; McGuire S
Clin Pediatr (Phila); 2023 May; 62(4):372-375. PubMed ID: 36171714
[No Abstract] [Full Text] [Related]
59. Don't miss the diagnosis: neurological manifestations as presenting features of COVID-19.
Madan A; Agarwal P; Ray S; Tyson B
Clin Med (Lond); 2023 Nov; 23(Suppl 6):7. PubMed ID: 38182227
[No Abstract] [Full Text] [Related]
60. Neurologic manifestations in children with COVID-19.
Gürlevik SL; Günbey C; Ozsurekci Y; Kesici S; Gocmen R; Temucin Ç; Özen S; Cengiz AB; Yalnızoglu D
Eur J Paediatr Neurol; 2022 Jul; 39():118-119. PubMed ID: 35781422
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
